Review article · 2020 · Open access

Targeting the alternative bile acid synthetic pathway for metabolic diseases

Wei Ping Jia, Meilin Wei, Cynthia Rajani, Xiaojiao Zheng

Protein & Cell, 12(5), 411–425 · Published 30 November 2020 · DOI 10.1007/s13238-020-00804-9

Open PDFView at the publisherCite this paper

In brief

“Targeting the alternative bile acid synthetic pathway for metabolic diseases” is a 2020 review article by Wei Ping Jia and 3 co-authors, published in Protein & Cell. OpenAlex counts 348 citations as of 21 November 2026, which puts it in the top 1% of works published in 2020 by citations. It is open access under a CC BY licence: the full text is free to read at Protein & Cell.

Citations
348
Most cited in
2024 (83)
Field-weighted impact
3.62
References
100
Authors
4

Abstract

The gut microbiota is profoundly involved in glucose and lipid metabolism, in part by regulating bile acid (BA) metabolism and affecting multiple BA-receptor signaling pathways. BAs are synthesized in the liver by multi-step reactions catalyzed via two distinct routes, the classical pathway (producing the 12α-hydroxylated primary BA, cholic acid), and the alternative pathway (producing the non-12α-hydroxylated primary BA, chenodeoxycholic acid). BA synthesis and excretion is a major pathway of cholesterol and lipid catabolism, and thus, is implicated in a variety of metabolic diseases including obesity, insulin resistance, and nonalcoholic fatty liver disease. Additionally, both oxysterols and BAs function as signaling molecules that activate multiple nuclear and membrane receptor-mediated signaling pathways in various tissues, regulating glucose, lipid homeostasis, inflammation, and energy expenditure. Modulating BA synthesis and composition to regulate BA signaling is an interesting and novel direction for developing therapies for metabolic disease. In this review, we summarize the most recent findings on the role of BA synthetic pathways, with a focus on the role of the alternative pathway, which has been under-investigated, in treating hyperglycemia and fatty liver disease. We also discuss future perspectives to develop promising pharmacological strategies targeting the alternative BA synthetic pathway for the treatment of metabolic diseases.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Jia, W. P., Wei, M., Rajani, C., & Zheng, X. (2020). Targeting the alternative bile acid synthetic pathway for metabolic diseases. Protein & Cell, 12(5), 411–425. https://doi.org/10.1007/s13238-020-00804-9

MLA 9

Jia, Wei Ping, et al. “Targeting the alternative bile acid synthetic pathway for metabolic diseases.” Protein & Cell, vol. 12, no. 5, 2020, pp. 411–425. https://doi.org/10.1007/s13238-020-00804-9.

Chicago

Jia, Wei Ping, Meilin Wei, Cynthia Rajani, and Xiaojiao Zheng. 2020. “Targeting the alternative bile acid synthetic pathway for metabolic diseases.” Protein & Cell 12 (5): 411–425. https://doi.org/10.1007/s13238-020-00804-9.

Harvard

Jia, W. P. et al. (2020) ‘Targeting the alternative bile acid synthetic pathway for metabolic diseases’, Protein & Cell, 12(5), pp. 411–425. doi:10.1007/s13238-020-00804-9.

IEEE

W. P. Jia, M. Wei, C. Rajani, and X. Zheng, “Targeting the alternative bile acid synthetic pathway for metabolic diseases,” Protein & Cell, vol. 12, no. 5, pp. 411–425, 2020, doi: 10.1007/s13238-020-00804-9.

BibTeX

@article{jia2020targeting,
  title     = {{Targeting the alternative bile acid synthetic pathway for metabolic diseases}},
  author    = {Jia, Wei Ping and Wei, Meilin and Rajani, Cynthia and Zheng, Xiaojiao},
  journal   = {Protein \& Cell},
  year      = {2020},
  volume    = {12},
  number    = {5},
  pages     = {411--425},
  doi       = {10.1007/s13238-020-00804-9},
  url       = {https://doi.org/10.1007/s13238-020-00804-9}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20212323
20224949
20236060
20248383
20257777
20265656

Its field-weighted citation impact is 3.62: it has been cited 3.62 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms

  • bile acid synthesis
  • chenodeoxycholic acid
  • cholic acid
  • gut microbiota
  • bile acid receptors
  • oxysterols
  • non-alcoholic fatty liver disease
  • obesity

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Jia, W. P., Wei, M., Rajani, C., & Zheng, X. (2020). Targeting the alternative bile acid synthetic pathway for metabolic diseases. Protein & Cell, 12(5), 411–425. https://doi.org/10.1007/s13238-020-00804-9

How many times has this paper been cited?

348 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Protein & Cell: sign in and open the PDF from this page.

Who wrote this paper?

Wei Ping Jia, Meilin Wei, Cynthia Rajani, Xiaojiao Zheng.

What is the DOI of this paper?

10.1007/s13238-020-00804-9, permanently at https://doi.org/10.1007/s13238-020-00804-9. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.